View Post

Injectable COVID-19 Treatment Approved for Infants

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) today announced the expanded approval of Veklury® (remdesivir) to include pediatric patients 28 days of age and older weighing at least 3 kilograms with positive results of direct SARS-CoV-2 viral testing.
This FDA action makes Veklury the first approved injectable COVID-19 treatment for children less than 12 years of age.
Under the expanded indication, a three-day Veklury treatment regimen is recommended to help prevent hospitalization in non-hospitalized COVID-19 pediatric patients at high risk for COVID-19 disease progression.

View Post

COVID-19 Confirmed More Costly and Fatal than Influenza

In COVID-19, Latest News by Precision Vaccinations

According to a recent retrospective cohort study conducted at the Hospital del Mar in Barcelona, Spain, when adults were hospitalized with COVID-19, they were at a greater risk of death than those with influenza.
After accounting for potential confounders, including age, comorbidities, sex, disease severity, pneumonia, and corticosteroid treatment, these researchers found that COVID-19 patients were more than three times as likely to die after being admitted to hospital than influenza patients.

View Post

COVID-19 Confirmed More Costly and Fatal than Influenza

In Influenza Vaccine News by Influenza Vaccine

According to a recent retrospective cohort study conducted at the Hospital del Mar in Barcelona, Spain, when adults were hospitalized with COVID-19, they were at a greater risk of death than those with influenza.
After accounting for potential confounders, including age, comorbidities, sex, disease severity, pneumonia, and corticosteroid treatment, these researchers found that COVID-19 patients were more than three times as likely to die after being admitted to hospital than influenza patients.